Incidence and prognostic impact of high-risk HPV tumor infection in cervical esophageal carcinoma

Journal of Gastrointestinal Oncology

Brian G. Czito¹  Christopher G. Willett¹  Manisha Palta¹  Ethan B. Ludmir¹  Xuefeng Zhang³  Yuan Wu² 

[1] Department of Radiation Oncology,Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USADepartment of Radiation Oncology,Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USADepartment of Radiation Oncology,Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA;Department of Biostatistics and Bioinformatics, Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USADepartment of Biostatistics and Bioinformatics, Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USADepartment of Biostatistics and Bioinformatics, Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA;Department of Pathology,Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USADepartment of Pathology,Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USADepartment of Pathology,Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA

关键词: Esophageal cancer;    chemoradiotherapy (CRT);    human papillomavirus (HPV);    cervical esophagus;   

DOI  :  10.3978/j.issn.2078-6891.2014.053

学科分类：肿瘤学

来源: Pioneer Bioscience Publishing Company

【 授权许可】

Unknown